Establishments primarily engaged in: (1) manufacturing bulk organic and inorganic medicinal chemicals and their derivatives and (2) processing (grading, grinding, and milling) bulk botanical drugs and herbs. Included in this industry are establishments primarily engaged in manufacturing agar-agar and similar products of natural origin, endocrine products, manufacturing or isolating basic vitamins, and isolating active medicinal principals such as alkaloids from botanical drugs and herbs.
The latest qualitative trends in the NAICS 2833 category, Medicinal Chemicals and Botanical Products, emphasize innovation combined with a shift toward sustainable practices. There is a significant increase in the development of plant-based pharmaceuticals and nutraceuticals, driven by consumer demand for natural and holistic health products. Companies are investing more in research and development to unlock the medicinal properties of various botanicals and integrate them into mainstream medicine.
Another notable trend is the adoption of advanced technologies such as AI and machine learning in drug discovery and development, expediting the process of identifying promising compounds. This technological integration promises not only faster time-to-market but also more cost-effective drug development pipelines.
Additionally, regulatory frameworks are evolving to support the faster approval of innovative medicinal and botanical products, particularly those that demonstrate significant therapeutic benefits with fewer side effects. This shift is expected to stimulate growth and encourage more startups to enter the market.
Looking ahead, the industry is forecasted to experience steady growth, bolstered by an aging global population and a rising prevalence of chronic diseases. The integration of personalized medicine approaches will further tailor treatments to individual patient profiles, enhancing efficacy and patient outcomes. Overall, the NAICS 2833 sector is poised for dynamic growth characterized by technological advancements and a stronger emphasis on sustainability and natural ingredients.
Adrenal derivatives: bulk, uncompounded
Agar-agar (ground)
Alkaloids and salts
Anesthetics, in bulk form
Antibiotics: bulk uncompounded
Atropine and derivatives
Barbituric acid and derivatives: bulk, uncompounded
Botanical products, medicinal: ground, graded, and milled
Brucine and derivatives
Caffeine and derivatives
Chemicals, medicinal: organic and inorganic bulk, uncompounded
Cinchona and derivatives
Cocaine and derivatives
Codeine and derivatives
Digitoxin
Drug grading, grinding, and milling
Endocrine products
Ephedrine and derivatives
Ergot alkaloids
Fish liver oils, refined and concentrated for medicinal use
Gland derivatives: bulk uncompounded
Glycosides
Herb grinding, grading, and milling
Hormones and derivatives
Insulin: bulk, uncompounded
Kelp plants
Mercury chlorides, U.S.P.
Mercury compounds, medicinal: organic and inorganic
Morphine and derivatives
Oils, vegetable and animal: medicinal grade refined and concentrated
Opium derivatives
Ox bile salts and derivatives: bulk, uncompounded
Penicillin: bulk, uncompounded
Physostigmine and derivatives
Pituitary gland derivatives: bulk, uncompounded
Procaine and derivatives: bulk, uncompounded
Quinine and derivatives
Reserpines
Salicylic acid derivatives, medicinal grade
Strychnine and derivatives
Sulfa drugs: bulk, uncompounded
Sulfonamides
Theobromine
Vegetable gelatin (agar-agar)
Vitamins, natural and synthetic: bulk, uncompounded
A review and comparison of financial performance of privately-help companies in specified SIC/NAICS industry segment, using industry standard benchmarks.
Answers come easily with iCFO. Review ROI, sales per employee, profit margins of the top 10%, top 25% and more, to identify areas of concern and opportunity. Examine what if scenarios and P&L impact of reducing costs or adding revenue.
It takes only five minutes to enter your data and produce a concise profile of your company’s fiscal state, including critical business ratios focusing on liquidity, profitability, asset efficiency, and growth.